PMID- 19300599
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110517
LR  - 20211020
IS  - 1176-6328 (Print)
IS  - 1178-2021 (Electronic)
IS  - 1176-6328 (Linking)
VI  - 3
IP  - 5
DP  - 2007
TI  - Increase of plasma brain-derived neurotrophic factor levels in two psychotic 
      depressed patients responding to lithium addition to paroxetine treatment.
PG  - 683-6
AB  - We report two patients with psychotic depression who were successfully treated 
      with a lithium addition to ongoing paroxetine treatment. In both cases, plasma 
      brain-derived neurotrophic factor (BDNF) levels increased about 2-fold after 
      lithium augmentation to paroxetine, compared with paroxetine treatment alone. 
      Plasma paroxetine levels did not change after lithium addition. These results 
      suggest that the increases in plasma BDNF levels reflect recovery from depressive 
      symptoms in psychotic depression.
FAU - Yoshimura, Reiji
AU  - Yoshimura R
AD  - Department of Psychiatry, University of Occupational and Environmental Health, 
      Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan.
FAU - Tsuji, Koshiro
AU  - Tsuji K
FAU - Ueda, Nobuhisa
AU  - Ueda N
FAU - Nakamura, Jun
AU  - Nakamura J
LA  - eng
PT  - Case Reports
PL  - New Zealand
TA  - Neuropsychiatr Dis Treat
JT  - Neuropsychiatric disease and treatment
JID - 101240304
PMC - PMC2656306
OTO - NOTNLM
OT  - brain-derived neurotrophic factor
OT  - lithium
OT  - paroxetine
OT  - psychotic depression
EDAT- 2007/10/01 00:00
MHDA- 2007/10/01 00:01
PMCR- 2008/02/01
CRDT- 2009/03/21 09:00
PHST- 2009/03/21 09:00 [entrez]
PHST- 2007/10/01 00:00 [pubmed]
PHST- 2007/10/01 00:01 [medline]
PHST- 2008/02/01 00:00 [pmc-release]
AID - ndt-3-683 [pii]
PST - ppublish
SO  - Neuropsychiatr Dis Treat. 2007;3(5):683-6.